In humans, a trinucleotide deletion in intron 13 of the Apbb1 gene was associated with a slight risk for early-onset of AD [54], while in hippocampal area CA4, increased Appb1 protein immunoreactivity seemed to be associated with the severity [55]. This evidence concerns the gene APBB1 and Alzheimer disease.